Soylar Öznur Kılıç, Kılınç Oğuz, Ellidokuz Hülya
Department of Chest Diseases, Dokuz Eylül University Faculty of Medicine, İzmir, Turkey.
Department of Preventive Oncology, Biostatistics Discipline, Dokuz Eylül University, İzmir, Turkey.
Turk Thorac J. 2015 Apr;16(2):64-67. doi: 10.5152/ttd.2015.4437. Epub 2015 Apr 1.
The purpose of our study was to compare community-acquired pneumonia (CAP) patients who were and were not administered treatment in accordance with the Turkish Thoracic Society (TTS) 2009 pneumonia guideline in terms of hospital stay length, treatment cost, and treatment efficacy.
Patients who were admitted to our hospital and who were diagnosed with CAP were included in the study. Demographic characteristics of the patients, symptoms at the time of diagnosis, physical examination, laboratory and radiological findings, treatments, response to treatment at follow-up, length of hospital stay, and direct cost of treatment were recorded in the TTS pneumonia database (TURCAP: TURKEY Community Acquired Pneumonia). Taking into consideration the "Turkish Thoracic Society Consensus Report on the Diagnosis and Treatment of Community-acquired pneumonia in Adults (2009)," the patients recorded in the database were evaluated in terms of conformity to the guideline.
This present study included 156 patients diagnosed with CAP. Sixty-six patients (42.3%) were females, and 96 (57.7%) were males, and the mean age of the patients was 70.4 years. The most common symptoms on admission were cough (94.9%), expectoration of purulent sputum (77.6%), and fever (58%). Comorbid diseases were chronic obstructive pulmonary disease (COPD; 29.5%), asthma (3.2%), lung cancer (8.3%), cardiovascular diseases (32.7%), and diabetes mellitus (12.8%). It was observed that 67.3% of the patients received treatment in accordance with the guideline. No significant difference was found in terms of gender and symptoms between the groups that received and did not receive treatment in accordance with the guideline. The mean age of the patients who received treatment according to the guideline was higher than that of the patients who did not receive treatment according to the guideline; COPD was more frequent in the group of patients who received treatment according to the guideline. Pneumonia Severity Index and Confusion, Urea, Respiratory rate, Blood pressure-Age>65 scores of the patients who were treated according to the guideline was higher and treatment resulted in death in 8% of these patients.
Hospital stay length, treatment cost, and treatment efficacy were similar in patients who were and were not administered treatment in accordance with the guideline.
我们研究的目的是比较按照土耳其胸科学会(TTS)2009年肺炎指南接受治疗和未接受治疗的社区获得性肺炎(CAP)患者在住院时间、治疗费用和治疗效果方面的差异。
纳入我院收治的诊断为CAP的患者。患者的人口统计学特征、诊断时的症状、体格检查、实验室和影像学检查结果、治疗情况、随访时的治疗反应、住院时间和治疗直接费用记录在TTS肺炎数据库(TURCAP:土耳其社区获得性肺炎)中。根据“土耳其胸科学会关于成人社区获得性肺炎诊断和治疗的共识报告(2009年)”,对数据库中记录的患者进行指南依从性评估。
本研究纳入了156例诊断为CAP的患者。66例(42.3%)为女性,96例(57.7%)为男性,患者的平均年龄为70.4岁。入院时最常见的症状为咳嗽(94.9%)、咳脓性痰(77.6%)和发热(58%)。合并症包括慢性阻塞性肺疾病(COPD;29.5%)、哮喘(3.2%)、肺癌(8.3%)、心血管疾病(32.7%)和糖尿病(12.8%)。观察到67.3%的患者按照指南接受治疗。在按照指南接受治疗和未接受治疗的组之间,在性别和症状方面未发现显著差异。按照指南接受治疗的患者的平均年龄高于未按照指南接受治疗的患者;COPD在按照指南接受治疗的患者组中更为常见。按照指南接受治疗的患者的肺炎严重指数和意识障碍、尿素、呼吸频率、血压-年龄>65评分更高,这些患者中有8%因治疗导致死亡。
按照指南接受治疗和未接受治疗的患者在住院时间、治疗费用和治疗效果方面相似。